SplenoMegaly Study : résultats intermédiaires
Guillaume Denis(Centre Hospitalier de Rochefort), Marc Berger(Université Clermont Auvergne), G. Urbanski(Centre Hospitalier Universitaire d'Angers), Louis Terriou(Centre Hospitalier Universitaire de Lille), Robert J. Costello(Hôpital de la Conception), Martin Michaud(Centre Hospitalier Universitaire de Toulouse), Thomas Sené(Hôpital de la Croix-Rousse), Audrey Lagadec(Sanofi (France)), Frédéric Bauduer(Centre National de la Recherche Scientifique), C. Rosé(Hôpital Saint-Vincent-de-Paul), L. Sanhes
Cited by 0
Related Papers
Proinflammatory Cytokines, Aging, and Age-Related Diseases
|Journal of the American Medical Directors Association|2013|1.1k
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
|New England Journal of Medicine|2010|385
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309